The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications

Current evidence does not support a clear role for pharmacotherapy in COVID-19. Without proper protection from bias and confounding, patients are exposed to treatments where the potential for benefit is at best unclear, yet the potential for harm from adverse effects is high.


Expert Opinion on Pharmacotherapy